Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON
  1. Home
  2. Azioni
  3. Svezia
  4. Nasdaq Stockholm
  5. Active Biotech AB (publ)
  6. Notizie
  7. Altre lingue
    ACTI   SE0001137985

ACTIVE BIOTECH AB (PUBL)

(ACTI)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su ACTIVE BIOTECH AB (PUBL)
03/10ACTIVE BIOTECH: Tasquinimod clinical  development in multiple myeloma advances into combi..
03/10Active Biotech Announces Tasquinimod Clinical Development in Multiple Myeloma Advances ..
31/08ACTIVE BIOTECH: Company presentation
05/08ACTIVE BIOTECH: Interim Report Jan-Jun 2021
05/08ACTIVE BIOTECH AB: Interim report January – June 2021
05/08Active Biotech AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2..
08/07Active Biotech's partner NeoTX will host KOL webinar on overcoming check point Inhibito..
05/07Active Biotech provides status update of its clinical naptumomab project
05/07Active Biotech AB Provides Status Update of its Clinical Naptumomab Project
19/05Annual General Meeting of Active Biotech AB
03/05ACTIVE BIOTECH: Company presentation May 2021
22/04Annual Report 2020 Active Biotech AB (publ)
22/04Active Biotech AB Interim report January – March 2021  
20/04ACTIVE BIOTECH: NOTICE of ANNUAL GENERAL MEETING OF SHAREHOLDERS
19/04Active Biotech and NeoTX Announce FDA Clearance of IND for Phase II Clinical Trial of N..
19/04Active Biotech and NeoTX announce FDA Clearance of IND for Phase II Clinical Trial of N..
31/03Number of shares and votes in Active Biotech
26/02Number of shares and votes in Active Biotech
11/02Active Biotech Year-end report January – December 2020  
04/02Active biotech enters into a manufacturing agreement with famar health care services fo..
26/01ACTIVE BIOTECH: rights issue heavily oversubscribed
07/01ACTIVE BIOTECH: Adjustment of period for trading in subscription rights and interim share..
05/01ACTIVE BIOTECH: publishes prospectus and certain new financial information included in th..
2020ACTIVE BIOTECH: Redeye initiates coverage of Active Biotech
2020Active Biotech Receive Milestone Payment From Neotx
2020Active Biotech Receive Milestone Payment from Neotx
2020Active Biotech's nomination committee appointed 
2020Report from extraordinary general meeting in Active Biotech and adjustment of previousl..
2020ACTIVE BIOTECH: announces the final terms of the rights issue
2020Active Biotech AB Appoints Elaine Sullivan as A Director
2020CORRECTION TO PREVIOUS PRESSRELEASE: Active Biotech updates its clinical strategy and pro..
2020CORRECTION TO PREVIOUS PRESSRELEASE: Active Biotech updates its clinical strategy and pro..
2020CORRECTION TO PREVIOUS PRESSRELEASE: Active Biotech updates its clinical strategy and pro..
2020Active Biotech AB Announces Updates of its Fully Owned Projects Tasquinimod and Laquini..
2020ACTIVE BIOTECH: Updates its clinical strategy and projected milestones
2020ACTIVE BIOTECH: Updates its clinical strategy and projected milestones
2020Active biotech updates its clinical strategy and projected milestones
2020ACTIVE BIOTECH: Invitation to Active Biotech's virtual capital markets day
2020ACTIVE BIOTECH: Invitation to Active Biotech's virtual capital markets day
2020Invitation to Active Biotech's virtual capital markets day
2020ACTIVE BIOTECH: Notice of extraordinary general meeting in active biotech
2020ACTIVE BIOTECH: Notice of extraordinary general meeting in active biotech
2020Notice of extraordinary general meeting in active biotech
2020ACTIVE BIOTECH: announces rights issue
2020ACTIVE BIOTECH: Interim report January – September 2020
2020ACTIVE BIOTECH: Interim report January – September 2020
2020Active Biotech Interim report January – September 2020
2020Active Biotech AB Publ Reports Earnings Results for the Third Quarter Ended September 3..
2020Active Biotech Interim Report January - June 2020
2020Active Biotech announces first patient dosed in phase 1b/2a study of tasquinimod use in..
2020Active Biotech Announces First Patient Dosed in Phase 1B/2A Study of Tasquinimod Use in..
2020Active Biotech provides status update in the portfolio projects
2020Active Biotech Provides Status Update in the Portfolio Projects
2020Annual General Meeting of Active Biotech AB
2020Active Biotech AB Announces Board Changes
2020ACTIVE BIOTECH PUBL: Annual Report 2019 Active Biotech AB (publ)
2020Active Biotech Interim Report January - March 2020
2020Active Biotech AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2..
2020ACTIVE BIOTECH: Notice of annual general meeting of shareholders
2020Active Biotech AB - Year-end report January - December 2019
2020Active Biotech AB Publ Reports Earnings Results for the Fourth Quarter Ended December 3..
2020Active Biotech announces new direction
2019Active Biotech's election committee appointed
2019Active Biotech Interim report January – September 2019
2019Active Biotech AB Publ Reports Earnings Results for the Third Quarter Ended September 3..
2019New preclinical data on naptumomab estafenatox will be presented at the Society for Imm..
2019Active Biotech and NeoTX today announce first patient dosed in the Phase 1b trial of na..
2019Active Biotech and NeoTX Announce First Patient Dosed in the Phase 1b Trial of Naptumom..
2019ACTIVE BIOTECH: New data on laquinimod from the Phase 2 LEGATO-HD study in Huntington's d..
2019Active Biotech Announces New Data from Exploratory Analysis of the Phase 2 LEGATO-HD St..
2019ACTIVE BIOTECH AB: Interim report January – June 2019
2019Active Biotech AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2..
2019Active Biotech AB Announces Board Appointments
2019ACTIVE BIOTECH: The Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be..
2019Active Biotech AB to Present Phase 2 LEGATO-HD Study of Laquinimod in Huntington's Dise..
1  2  3Pross.
Prossimo evento su ACTIVE BIOTECH AB (PUBL)
04/11/21